Boothbay Fund Management’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-40,600
| Closed | -$614K | – | 2438 |
|
|
2022
Q3 | $614K | Buy |
+40,600
| New | +$614K | 0.02% | 978 |
|
|
2020
Q1 | – | Sell |
-20,000
| Closed | -$483K | – | 1052 |
|
|
2019
Q4 | $483K | Buy |
20,000
+7,451
| +59% | +$180K | 0.04% | 422 |
|
|
2019
Q3 | $241K | Buy |
+12,549
| New | +$241K | 0.02% | 525 |
|
|
2018
Q4 | – | Sell |
-5,000
| Closed | -$308K | – | 883 |
|
|
2018
Q3 | $308K | Buy |
+5,000
| New | +$308K | 0.03% | 388 |
|
|
2017
Q3 | – | Sell |
-7,965
| Closed | -$419K | – | 745 |
|
|
2017
Q2 | $419K | Buy |
+7,965
| New | +$419K | 0.09% | 240 |
|